LOS ANGELES CAPITAL MANAGEMENT LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 187 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$990,044
-23.1%
32,270
+0.4%
0.00%
-20.0%
Q2 2023$1,287,489
+202.2%
32,131
+301.5%
0.01%
+150.0%
Q3 2022$426,000
-8.8%
8,0020.0%0.00%0.0%
Q2 2022$467,000
-40.5%
8,002
-22.2%
0.00%
-33.3%
Q1 2022$785,000
+36.5%
10,281
+7.7%
0.00%
+50.0%
Q4 2021$575,000
+7.1%
9,550
-0.5%
0.00%0.0%
Q3 2021$537,000
-11.7%
9,597
-4.2%
0.00%
-33.3%
Q2 2021$608,000
-34.7%
10,022
-24.5%
0.00%
-25.0%
Q1 2021$931,000
-35.3%
13,277
-44.8%
0.00%
-33.3%
Q4 2020$1,440,000
+0.7%
24,068
+1.2%
0.01%
-14.3%
Q3 2020$1,430,000
-39.2%
23,793
-46.9%
0.01%
-36.4%
Q2 2020$2,353,000
+58.1%
44,847
+1.1%
0.01%
+22.2%
Q1 2020$1,488,000
+608.6%
44,364
+856.3%
0.01%
+800.0%
Q4 2019$210,000
-50.8%
4,639
-58.6%
0.00%
-50.0%
Q3 2019$427,000
-52.2%
11,215
-45.5%
0.00%
-60.0%
Q2 2019$894,000
-4.6%
20,560
-16.5%
0.01%0.0%
Q1 2019$937,000
+73.5%
24,620
+96.0%
0.01%
+66.7%
Q4 2018$540,000
+9.8%
12,560
+25.4%
0.00%0.0%
Q3 2018$492,000
+57.7%
10,015
+2.8%
0.00%
+50.0%
Q2 2018$312,000
+43.8%
9,745
+217.9%
0.00%0.0%
Q2 2015$217,0003,0650.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 563,415$21,753,4534.80%
Gagnon Advisors, LLC 180,331$6,962,5794.70%
Spyglass Capital Management LLC 868,686$33,539,9662.69%
Tamarack Advisers, LP 100,000$3,861,0001.99%
ARMISTICE CAPITAL, LLC 1,892,000$73,050,1201.27%
NEUMEIER POMA INVESTMENT COUNSEL LLC 276,590$10,679,1400.99%
RICE HALL JAMES & ASSOCIATES, LLC 437,285$16,883,5740.97%
Rock Springs Capital Management LP 1,032,600$39,868,6860.96%
OUTFITTER FINANCIAL LLC 25,860$998,4550.91%
Stephens Investment Management Group LLC 1,168,469$45,535,2370.82%
View complete list of PACIRA PHARMACEUTICALS INC shareholders